Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PLASMA KALLIKREIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 128 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Colman, RW
      Role of the light chain of high molecular weight kininogen in adhesion, cell-associated proteolysis and angiogenesis

      BIOLOGICAL CHEMISTRY
    2. Oliva, MLV; Santomauro-Vaz, EM; Andrade, SA; Juliano, MA; Pott, VJ; Sampaio, MU; Sampaio, CAM
      Synthetic peptides and fluorogenic substrates related to the reactive sitesequence of Kunitz-type inhibitors isolated from Bauhinia: Interaction with human plasma kallikrein

      BIOLOGICAL CHEMISTRY
    3. Uknis, AB; DeLa Cadena, RA; Janardham, R; Sartor, RB; Whalley, ET; Colman, RW
      Bradykinin receptor antagonists type 2 attenuate the inflammatory changes in peptidoglycan-induced acute arthritis in the Lewis rat

      INFLAMMATION RESEARCH
    4. Kramoroff, A; Nigretto, JM
      In vitro factor XI activation mechanism according to an optimized model ofactivated partial thromboplastin time test

      BLOOD COAGULATION & FIBRINOLYSIS
    5. Tada, M; Tsuda, Y; Wanaka, K; Hijikata-Okunomiya, A; Horie, N; Okamoto, U; Okamoto, S; Okada, Y
      Isolation of plasma kallikrein by high efficiency affinity chromatography and its characterization

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    6. Loureiro-Silva, MR; Molina, HM; Borges, DR
      Portal hypertensive response to bradykinin in inflamed or cirrhotic rat livers is mediated by B-2-type receptors

      JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    7. Motta, G; Shariat-Madar, Z; Mahdi, F; Sampaio, CAM; Schmaier, AH
      Assembly of high molecular weight kininogen and activation of prekallikrein on cell matrix

      THROMBOSIS AND HAEMOSTASIS
    8. Neth, P; Arnhold, M; Nitschko, H; Fink, E
      The mRNAs of prekallikrein, factors XI and XII, and kininogen, components of the contact phase cascade are differentially expressed in multiple non-hepatic human tissues

      THROMBOSIS AND HAEMOSTASIS
    9. Rampazzo, P; Biasiolo, A; Garin, J; Rosato, A; Betterle, C; Ruffatti, A; Pengo, V
      Some patients with antiphospholipid syndrome express hitherto undescribed antibodies to cardiolipin-binding proteins

      THROMBOSIS AND HAEMOSTASIS
    10. Borsody, MK; Coco, ML
      A hypothesis accounting for the inconsistent benefit of glucocorticoid therapy in closed head trauma

      MEDICAL HYPOTHESES
    11. Pando, SC; Oliva, MLV; Sampaio, CAM; Di Ciero, L; Novello, JC; Marangoni, S
      Primary sequence determination of a Kunitz inhibitor isolated from Delonixregia seeds

      PHYTOCHEMISTRY
    12. Tsuda, Y; Tada, M; Wanaka, K; Okamoto, U; Hijikata-Okunomiya, A; Okamoto, S; Okada, Y
      Structure-inhibitory activity relationship of plasmin and plasma kallikrein inhibitors

      CHEMICAL & PHARMACEUTICAL BULLETIN
    13. Mojcik, CF; Levy, JH
      Aprotinin and the systemic inflammatory response after cardiopulmonary bypass

      ANNALS OF THORACIC SURGERY
    14. Melo, RL; Alves, LC; Del Nery, E; Juliano, L; Juliano, MA
      Synthesis and hydrolysis by cysteine and serine proteases of short internally quenched fluorogenic peptides

      ANALYTICAL BIOCHEMISTRY
    15. Sriskandan, S; Cohen, J
      Kallikrein-kinin system activation in streptococcal toxic shock syndrome

      CLINICAL INFECTIOUS DISEASES
    16. Kimura, A; Kihara, T; Okimura, H; Hamabata, T; Ohnishi, J; Moriyama, A; Takahashi, K; Takahashi, T
      Identification of porcine follipsin as plasma kallikrein, and its possibleinvolvement in the production of bradykinin within the follicles of porcine ovaries

      MOLECULAR REPRODUCTION AND DEVELOPMENT
    17. Izutani, W; Fujita, M; Nishizawa, K; Koga, J
      Urinary protein C inhibitor as a therapeutic agent to disseminated intravascular coagulation (DIC): A comparison with low molecular weight heparin inrats with lipopolysaccharide-induced DIC

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    18. Fujita, M; Izutani, W; Komurasaki, Y
      Effect of urinary protein C inhibitor on lipopolysacsharide-induced disseminated intravascular coagulation in rats

      THROMBOSIS AND HAEMOSTASIS
    19. Oliva, MLV; Souza-Pinto, JC; Batista, IFC; Araujo, MS; Silveira, VF; Auerswald, EA; Mentele, R; Eckerskorn, C; Sampaio, MU; Sampaio, CAM
      Leucaena leucocephala serine proteinase inhibitor: primary structure and action on blood coagulation, kinin release and rat paw edema

      BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
    20. Nagaoka, MR; Kouyoumdjian, M; Borges, DR
      The hepatic clearance of recombinant tissue-type plasminogen activator decreases after an inflammatory stimulus

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    21. Sriskandan, S; Kemball-Cook, G; Moyes, D; Canvin, J; Tuddenham, E; Cohen, J
      Contact activation in shock caused by invasive group A Streptococcus pyogenes

      CRITICAL CARE MEDICINE
    22. Pokhilko, AV
      Intrinsic coagulation pathway: An activation threshold

      THROMBOSIS RESEARCH
    23. Caliezi, C; Wuillemin, WA; Zeerleder, S; Redondo, M; Eisele, B; Hack, CE
      C1-esterase inhibitor: An anti-inflammatory agent and its potential use inthe treatment of diseases other than hereditary angioedema

      PHARMACOLOGICAL REVIEWS
    24. Miyoshi, S
      Effects of Vibrio vulnificus metalloprotease on the capillaries: Pathological actions and inactivation by alpha-macroglobulin

      YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
    25. Lockyer, AE; Jones, CS; Noble, LR; Rollinson, D
      Use of differential display to detect changes in gene expression in the intermediate snail host Biomphalaria glabrata upon infection with Schistosomamansoni

      PARASITOLOGY
    26. Persson, K; Morgelin, M; Lindbom, L; Alm, P; Bjorck, L; Herwald, H
      Severe lung lesions caused by Salmonella are prevented by inhibition of the contact system

      JOURNAL OF EXPERIMENTAL MEDICINE
    27. Zito, F; Drummond, F; Bujac, SR; Esnouf, MP; Morrissey, JH; Humphries, SE; Miller, GJ
      Epidemiological and genetic associations of activated factor XII concentration with factor VII activity, fibrinopeptide A concentration, and risk of coronary heart disease in men

      CIRCULATION
    28. Okada, Y; Tsuda, Y; Tada, M; Wanaka, K; Okamoto, U; Hijikata-Okunomiya, A; Okamoto, S
      Development of potent and selective plasmin and plasma kallikrein inhibitors and studies on the structure-activity relationship

      CHEMICAL & PHARMACEUTICAL BULLETIN
    29. Lin, YZ; Pixley, RA; Colman, RW
      Kinetic analysis of the role of zinc in the interaction of domain 5 of high-molecular weight kininogen (HK) with heparin

      BIOCHEMISTRY
    30. Hermann, A; Arnhold, M; Kresse, H; Neth, P; Fink, E
      Expression of plasma prekallikrein mRNA in human nonhepatic tissues and cell lineages suggests special local functions of the enzyme

      BIOLOGICAL CHEMISTRY
    31. Schousboe, I; Feddersen, K; Rojkjaer, R
      Factor XIIa is a kinetically favorable plasminogen activator

      THROMBOSIS AND HAEMOSTASIS
    32. Murata, M; Ohnishi, J; Kudo, T; Wada, S; Yoshida, H; Fujimoto, S; Takahashi, T
      Proteolytic activation of single-chain tissue-type plasminogen activator by protease/alpha(2)-macroglobulin complex isolated from human ovarian follicular fluid

      ZOOLOGICAL SCIENCE
    33. Mashiko, H; Miyamoto, K; Takahashi, H
      Cleavage of porcine high molecular weight kininogen by the action of porcine pancreatic kallikrein

      IMMUNOPHARMACOLOGY
    34. Takano, M; Horie, M; Narahara, M; Miyake, M; Okamoto, H
      Expression of kininogen mRNAs and plasma kallikrein mRNA by cultured neurons, astrocytes and meningeal cells in the rat brain

      IMMUNOPHARMACOLOGY
    35. Oliva, MLV; Andrade, S; Batista, IFC; Sampaio, MU; Juliano, M; Fritz, H; Auerswald, EA; Sampaio, CAM
      Human plasma kallikrein and tissue kallikrein binding to a substrate basedon the reactive site of a factor Xa inhibitor isolated from Bauhinia ungulata seeds

      IMMUNOPHARMACOLOGY
    36. Cerf, M; Raidoo, D; Fink, E; Fritz, H; Bhoola, K
      Plasma kallikrein localisation in human blood vessels

      IMMUNOPHARMACOLOGY
    37. Shcherbakova, I; Neshkova, E; Dotsenko, V; Platonova, T; Shcherbakova, E; Yarovaya, G
      The possible role of plasma kallikrein-kinin system and leukocyte elastasein pathogenesis of schizophrenia

      IMMUNOPHARMACOLOGY
    38. Fukumizu, A; Tsuda, Y; Wanaka, K; Tada, M; Okamoto, S; Hijikata-Okunomiya, A; Okada, Y
      Amino acids and peptides. LIII. Synthesis and biological activities of some pseudo-peptide analogs of PKSI-527, a plasma kallikrein selective inhibitor: The importance of the peptide backbone

      CHEMICAL & PHARMACEUTICAL BULLETIN
    39. Prendes, MJ; Bielek, E; Zechmeister-Machhart, M; Vanyek-Zavadil, E; Carroll, VA; Breuss, J; Binder, BR; Geiger, M
      Synthesis and ultrastructural localization of protein C inhibitor in humanplatelets and megakaryocytes

      BLOOD
    40. Okada, Y; Tsuda, Y; Tada, M; Wanaka, K; Hijikata-Okunomiya, A; Okamoto, U; Okamoto, S
      Development of plasma kallikrein selective inhibitors

      BIOPOLYMERS
    41. Bueno, NR; Fritz, H; Auerswald, EA; Mentele, R; Sampaio, M; Sampaio, CAM; Oliva, MLV
      Primary structure of Dioclea glabra trypsin inhibitor, DgTI, a Bowman-Birkinhibitor

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    42. GARRETT GS; CORREA PE; MCPHAIL SJ; TORNHEIM K; BURTON JA; EICKHOFF DJ; ENGERHOLM GG; MCIVER JM
      PEPTIDE ALDEHYDE INHIBITORS OF THE KALLIKREINS - AN INVESTIGATION OF SUBSITE INTERACTIONS WITH TRIPEPTIDES CONTAINING STRUCTURAL VARIATIONSAT THE AMINO-TERMINUS

      The journal of peptide research
    43. JONES DW; GALLIMORE MJ; WINTER M
      AN AUTOMATED CHROMOGENIC PEPTIDE SUBSTRATE ASSAY FOR COAGULATION-FACTOR-XII

      Blood coagulation & fibrinolysis
    44. TADA M; WANAKA K; OKAMOTO S; OKAMOTO U; NAKAYA Y; HORIE N; HIJIKATAOKUNOMIYA A; TSUDA Y; OKADA Y
      PURIFICATION METHOD FOR HUMAN PLASMA KALLIKREIN BY A NEW AFFINITY-CHROMATOGRAPHY

      Biological & pharmaceutical bulletin
    45. SAKAKIBARA T; HINTZE TH; NASJLETTI A
      DETERMINANTS OF KININ RELEASE IN ISOLATED RAT HINDQUARTERS

      American journal of physiology. Regulatory, integrative and comparative physiology
    46. HARPER PL; TAYLOR FB; DELACADENA RA; COURTNEY M; COLMAN RW; CARRELL RW
      RECOMBINANT ANTITRYPSIN PITTSBURGH UNDERGOES PROTEOLYTIC CLEAVAGE DURING ESCHERICHIA-COLI SEPSIS AND FAILS TO PREVENT THE ASSOCIATED COAGULOPATHY IN A PRIMATE MODEL

      Thrombosis and haemostasis
    47. MASHIKO H; MIYAMOTO K; TAKAHASHI H
      STUDIES ON PORCINE HIGH-MOLECULAR-WEIGHT KININOGEN - AN IMPROVED METHOD FOR THE PURIFICATION OF PORCINE HIGH-MOLECULAR-WEIGHT KININOGEN ANDCLEAVAGE OF THE KININOGEN BY THE ACTION OF PORCINE PLASMA KALLIKREIN

      Comparative biochemistry and physiology. B. Comparative biochemistry
    48. Braulio, VB; Kouyoumdjian, M; Zucoloto, S; Figueiredo, F; Borges, DR
      Plasma-kallikrein clearance during liver regeneration after partial hepatectomy in the rat

      LIVER
    49. SANCHEZ J; ELGUE G; RIESENFELD J; OLSSON P
      STUDIES OF ADSORPTION, ACTIVATION, AND INHIBITION OF FACTOR-XII ON IMMOBILIZED HEPARIN

      Thrombosis research
    50. ROTHSCHILD AM; GOMES ELT; FORTUNATO IC
      BRADYKININ RELEASE FROM HIGH-MOLECULAR-WEIGHT KININOGEN AND INCREASE IN PLASMA KALLIKREIN-LIKE ACTIVITY FOLLOWING SENSORY STIMULATION BY FOOD IN THE RAT

      Naunyn-Schmiedeberg's archives of pharmacology
    51. TORTI SV; TORTI FM
      HUMAN H-KININOGEN IS A FERRITIN-BINDING PROTEIN

      The Journal of biological chemistry
    52. STADNICKI A; SARTOR RB; JANARDHAM R; STADNICKA I; ADAM AA; BLAIS C; COLMAN RW
      KALLIKREIN-KININOGEN SYSTEM ACTIVATION AND BRADYKININ (B2) RECEPTORS IN INDOMETHACIN-INDUCED ENTEROCOLITIS IN GENETICALLY SUSCEPTIBLE LEWISRATS

      Gut
    53. KIM DR; KANG KW
      AMINO-ACID-SEQUENCE OF PIGUAMERIN, AN ANTISTASIN-TYPE PROTEASE INHIBITOR FROM THE BLOOD SUCKING LEECH HIRUDO-NIPPONIA

      European journal of biochemistry
    54. TSUDA Y; WANAKA K; TADA M; OKAMOTO S; HIJIKATAOKUNOMIYA A; OKADA Y
      DESIGN OF PLASMA KALLIKREIN INHIBITORS - FUNCTIONAL AND STRUCTURAL REQUIREMENTS OF PLASMA KALLIKREIN INHIBITORS

      Chemical and Pharmaceutical Bulletin
    55. SHIBAYAMA Y; REDDIGARI SR; TERUYA M; NAKAMURA K; FUKUNAGA Y; IENAGA K; NISHIKAWA K; SUEHIRO S; KAPLAN AP
      EFFECT OF NEUROTROPIN(R) ON THE BINDING OF HIGH-MOLECULAR-WEIGHT KININOGEN AND HAGEMAN-FACTOR TO HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS ANDTHE AUTOACTIVATION OF BOUND HAGEMAN-FACTOR

      Biochemical pharmacology
    56. NAGAOKA MR; KOUYOUMDJIAN M; BORGES DR
      VENA-CAVA PERFUSION IN-SITU - A TOOL FOR UPTAKE STUDIES

      Journal of pharmacological and toxicological methods
    57. ZHANG M; PENG B; NIEHUS J; BAUMGARTEN CR; BRUNNEE T; THALHOFER S; DOROW P; KUNKEL G
      KININ GENERATION IN ACUTE PNEUMONIA AND CHRONIC-BRONCHITIS

      The European respiratory journal
    58. WIRSCHING F; OPITZ T; DIETRICH R; SCHWIENHORST A
      DISPLAY OF FUNCTIONAL THROMBIN INHIBITOR HIRUDIN ON THE SURFACE OF PHAGE M13

      Gene
    59. SCHMAIER AH
      CONTACT ACTIVATION - A REVISION

      Thrombosis and haemostasis
    60. YOKOI T; TAGUCHI H; NISHIYAMA Y; IGARASHI K; KASUYA F; OKADA Y
      AMINO-ACIDS AND PEPTIDES .48. STUDIES ON THE STRUCTURE OF AN UNEXPECTED REACTION-PRODUCT FROM DIPEPTIDYL CHLOROMETHYL KETONE DURING ACID-HYDROLYSIS

      Journal of chemical research. Synopses
    61. MASHIKO H; TAKAHASHI H
      CANINE PLASMA KININOGEN - EVIDENCE FOR THE PRESENCE OF 2 KININOGENS AND PURIFICATION OF HIGH-MOLECULAR-WEIGHT KININOGEN AND CHARACTERIZATION AS MULTI FUNCTIONAL MOLECULE

      Comparative biochemistry and physiology. B. Comparative biochemistry
    62. GILLIS S; FURIE BC; FURIE B
      INTERACTIONS OF NEUTROPHILS AND COAGULATION PROTEINS

      Seminars in hematology
    63. OHISHI S
      REGULATION OF BIOLOGICAL FUNCTIONS BY THE KALLIKREIN-KININ SYSTEM

      Yakugaku zasshi
    64. VELTHUIS HT; BAUFRETON C; JANSEN PGM; THIJS CM; HACK CE; STURK A; WILDEVUUR CRH; LOISANCE DY
      HEPARIN COATING OF EXTRACORPOREAL CIRCUITS INHIBITS CONTACT ACTIVATION DURING CARDIAC OPERATIONS

      Journal of thoracic and cardiovascular surgery
    65. COLMAN RW; SCHMAIER AH
      CONTACT SYSTEM - A VASCULAR BIOLOGY MODULATOR WITH ANTICOAGULANT, PROFIBRINOLYTIC, ANTIADHESIVE, AND PROINFLAMMATORY ATTRIBUTES

      Blood
    66. HILL GE; TAYLOR JA; ROBBINS RA
      DIFFERING EFFECTS OF APROTININ AND EPSILON-AMINOCAPROIC ACID ON CYTOKINE-INDUCED INDUCIBLE NITRIC-OXIDE SYNTHASE EXPRESSION

      The Annals of thoracic surgery
    67. GAUTHIER M; PATSTON PA
      REACTIVATION OF C1-INHIBITOR POLYMERS BY DENATURATION AND GEL-FILTRATION CHROMATOGRAPHY

      Analytical biochemistry
    68. LEY AC; MARKLAND W; LADNER RC
      OBTAINING A FAMILY OF HIGH-AFFINITY, HIGH-SPECIFICITY PROTEIN INHIBITORS OF PLASMIN AND PLASMA KALLIKREIN

      Molecular diversity
    69. SPANNAGL M; HENSELMANN P; WEBER M; GRAM J; JESPERSEN J; KLUFT C
      FACTOR-XII DEPENDENT FIBRINOLYTIC-ACTIVITY IS DECREASED IN THE ACUTE-PHASE OF MYOCARDIAL OR CEREBRAL INFARCTION

      Fibrinolysis
    70. MCCARTHY DA; MACEY MG
      NOVEL ANTICOAGULANTS FOR FLOW CYTOMETRIC ANALYSIS OF LIVE LEUKOCYTES IN WHOLE-BLOOD

      Cytometry
    71. SOUZAPINTO JC; OLIVA MLV; SAMPAIO CAM; DAMES J; AUERSWALD EA; LIMAOS E; FRITZ H; SAMPAIO MU
      EFFECT OF A SERINE PROTEINASE-INHIBITOR FROM LEUCAENA-LEUCOCEPHALA ONPLASMA KALLIKREIN AND PLASMIN

      Immunopharmacology
    72. COLMAN RW
      INHIBITORY AND ANTIADHESIVE PROPERTIES OF HUMAN KININOGENS

      Immunopharmacology
    73. NAGAOKA MR; KOUYOUMDJIAN M; BORGES DR
      PLASMA KALLIKREIN AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR COMPETE FOR ACOMMON PATHWAY INTO THE LIVER

      Immunopharmacology
    74. EVANS DM; JONES DM; PITT GR; SUEIRASDIAZ J; HORTON J; ASHWORTH D; OLSSON H; SZELKE M
      SELECTIVE INHIBITORS OF PLASMA KALLIKREIN

      Immunopharmacology
    75. DOTSENKO V; NESHKOVA E; NAMAZOVA I; VAVILOVA L; YAROVAYA G
      HAGEMAN-FACTOR AND KALLIKREIN IN PATHOGENESIS OF SENILE CATARACTS ANDTHE PSEUDOEXFOLIATION SYNDROME

      Immunopharmacology
    76. NAGAOKA MR; KOUYOUMDJIAN M; BORGES DR
      CLEARANCE OF THE ALPHA(2)MACROGLOBULIN-TRYPSIN COMPLEX AND UPTAKE OF TRYPSIN BY PERFUSED LIVER

      Brazilian journal of medical and biological research
    77. KATSUURA Y; OKAMOTO S; OHNO N; WANAKA K
      EFFECTS OF A HIGHLY SELECTIVE SYNTHETIC INHIBITOR OF PLASMA KALLIKREIN ON DISSEMINATED INTRAVASCULAR COAGULATION IN RATS

      Thrombosis research
    78. WALLACE EM; FEIGHERY C; JACKSON J
      A SOLID-PHASE ANTIBODY-CAPTURE ASSAY FOR THE MEASUREMENT OF CL-INHIBITOR CONSUMPTION IN-VIVO

      Scandinavian journal of clinical & laboratory investigation
    79. IMAMURA T; DUBIN A; MOORE W; TANAKA R; TRAVIS J
      INDUCTION OF VASCULAR-PERMEABILITY ENHANCEMENT BY HUMAN TRYPTASE - DEPENDENCE ON ACTIVATION OF PREKALLIKREIN AND DIRECT RELEASE OF BRADYKININ FROM KININOGENS

      Laboratory investigation
    80. ZAHEDI R; AULAK KS; ELDERING E; DAVIS AE
      CHARACTERIZATION OF C1 INHIBITOR-TA - A DYSFUNCTIONAL C1INH WITH DELETION OF LYSINE-251

      The Journal of biological chemistry
    81. MURAKAMI N; TAKASE H; TOMITA T; IWATA K; NARUSE T
      ANTINOCICEPTIVE ACTIVITY OF A NOVEL NONSTEROIDAL ANTIINFLAMMATORY DRUG (M-5011) WITH LOW ULCEROGENIC EFFECTS IN MICE

      Japanese Journal of Pharmacology
    82. JANSEN PM; PIXLEY RA; BROUWER M; DEJONG IW; CHANG ACK; HACK CE; TAYLOR FB; COLMAN RW
      INHIBITION OF FACTOR-XII IN SEPTIC BABOONS ATTENUATES THE ACTIVATION OF COMPLEMENT AND FIBRINOLYTIC SYSTEMS AND REDUCES THE RELEASE OF INTERLEUKIN-6 AND NEUTROPHIL ELASTASE

      Blood
    83. TANAKA K; EINAGA K; TSUCHIYAMA H; TAIT JF; FUJIKAWA K
      PREPARATION AND CHARACTERIZATION OF A DISULFIDE-LINKED BIOCONJUGATE OF ANNEXIN-V WITH THE B-CHAIN OF UROKINASE - AN IMPROVED FIBRINOLYTIC AGENT TARGETED TO PHOSPHOLIPID-CONTAINING THROMBI

      Biochemistry
    84. BUHLER R; HOVINGA JK; AEBIHUBER I; FURLAN M; LAMMLE B
      IMPROVED DETECTION OF PROTEOLYTICALLY CLEAVED HIGH-MOLECULAR-WEIGHT KININOGEN BY IMMUNOBLOTTING USING AN ANTISERUM AGAINST ITS REDUCED 47 KDA LIGHT-CHAIN

      Blood coagulation & fibrinolysis
    85. HACK CE
      MONITORING OF IMMUNOTHERAPY WITH CYTOKINES OR MONOCLONAL-ANTIBODIES

      Cytotechnology
    86. PU XP; NAGASAWA S
      PURIFICATION AND CHARACTERIZATION OF PK-120, A NOVEL SUBSTRATE FOR PLASMA KALLIKREIN, FROM GUINEA-PIG PLASMA

      Biological & pharmaceutical bulletin
    87. WRIGHT HT; SCARSDALE JN
      STRUCTURAL BASIS FOR SERPIN INHIBITOR ACTIVITY

      Proteins
    88. PIXLEY RA; ZELLIS S; BANKES P; DELACADENA RA; PAGE JD; SCOTT CF; KAPPELMAYER J; WYSHOCK EG; KELLY JJ; COLMAN RW
      PROGNOSTIC VALUE OF ASSESSING CONTACT SYSTEM ACTIVATION AND FACTOR-V IN SYSTEMIC INFLAMMATORY RESPONSE SYNDROME

      Critical care medicine
    89. ALCARAZ A; ESPANA F; SANCHEZCUENCA J; ZUAZU I; ESTELLES A; AZNAR J; VICENTE V
      ACTIVATION OF THE PROTEIN-C PATHWAY IN ACUTE SEPSIS

      Thrombosis research
    90. BRISEID K; HOEM NO; JOHANNESEN S; HAUG K
      AMIDOLYTIC ASSAY OF FACTOR-XI IN HUMAN PLASMA - SIGNIFICANCE OF KALLIKREIN FOR THE ACTIVITY MEASURED

      Thrombosis research
    91. WENDEL HP; HELLER W; MICHEL J; MAYER G; OCHSENFAHRT C; GRAETER U; SCHULZE J; HOFFMEISTER HM; HOFFMEISTER HE
      LOWER CARDIAC TROPONIN-T LEVELS IN PATIENTS UNDERGOING CARDIOPULMONARY BYPASS AND RECEIVING HIGH-DOSE APROTININ THERAPY INDICATE REDUCTION OF PERIOPERATIVE MYOCARDIAL DAMAGE

      Journal of thoracic and cardiovascular surgery
    92. CHACKO S; SILVERTON E; KAMMORGAN L; SMITHGILL S; COHEN G; DAVIES D
      STRUCTURE OF AN ANTIBODY LYSOZYME COMPLEX UNEXPECTED EFFECT OF A CONSERVATIVE MUTATION

      Journal of Molecular Biology
    93. ZAHEDI R; BISSLER JJ; DAVIS AE; ANDREADIS C; WISNIESKI JJ
      UNIQUE C1 INHIBITOR DYSFUNCTION IN A KINDRED WITHOUT ANGIOEDEMA .2. IDENTIFICATION OF AN ALA(443)-]VAL SUBSTITUTION AND FUNCTIONAL-ANALYSISOF THE RECOMBINANT MUTANT PROTEIN

      The Journal of clinical investigation
    94. ELDERING E; VERPY E; ROEM D; MEO T; TOSI M
      COOH-TERMINAL SUBSTITUTIONS IN THE SERPIN C1 INHIBITOR THAT CAUSE LOOP OVERINSERTION AND SUBSEQUENT MULTIMERIZATION

      The Journal of biological chemistry
    95. OHNISHI J; KIHARA T; HAMABATA T; TAKAHASHI K; TAKAHASHI T
      CLEAVAGE SPECIFICITY OF PORCINE FOLLIPSIN

      The Journal of biological chemistry
    96. PATSTON PA; HAUERT J; MICHAUD M; SCHAPIRA M
      FORMATION AND PROPERTIES OF C1-INHIBITOR POLYMERS

      FEBS letters
    97. NISHIMURA H; KAKIZAKI I; MUTA T; SASAKI N; PU PX; YAMASHITA T; NAGASAWA S
      CDNA AND DEDUCED AMINO-ACID-SEQUENCE OF HUMAN PK-120, A PLASMA KALLIKREIN-SENSITIVE GLYCOPROTEIN

      FEBS letters
    98. UENO A; ISHIDA H; OHISHI S
      COMPARATIVE-STUDY OF ENDOTOXIN-INDUCED HYPOTENSION IN KININOGEN-DEFICIENT RATS WITH THAT IN NORMAL RATS

      British Journal of Pharmacology
    99. NAKAMURA M; TOMOO K; ISHIDA T; TAGUCHI H; TSUDA Y; OKADA Y; OKUNOMIYA A; WANAKA K; OKAMOTO S
      DESIGN OF NONCOVALENT TRYPSIN-INHIBITOR BASED ON THE X-RAY CRYSTAL-STRUCTURE OF THE COMPLEX

      Biochemical and biophysical research communications
    100. MAJIMA M; KATORI M
      APPROACHES TO THE DEVELOPMENT OF NOVEL ANTIHYPERTENSIVE DRUGS - CRUCIAL ROLE OF THE RENAL KALLIKREIN-KININ SYSTEM

      Trends in pharmacological sciences


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 19:57:06